Mixed Chimeric Transplantation for Primary Amyloidosis

NCT00186095 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-06-23

No results posted yet for this study

Summary

To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.

Conditions

  • Amyloidosis

Interventions

PROCEDURE

autologous followed by nonmyeloablative allogeneic transplant

Sponsors & Collaborators

Principal Investigators

  • Keith Stockerl-Goldstein, MD · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Completion
2006-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186095 on ClinicalTrials.gov